Formulary Search
A to Z of Drugs : R
Records returned : 81 (on 28 May 2025 at 04:55:05).
Show Icon and Status Keys
Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
2nd line in adults without swallowing difficulties. (Suitable for patients that cannot have animal-derived products / capsules.)
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Off-label use. Specialist initiation and prescribing for at least 1 month before any request is made for primary care prescribing.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Only recommended as an option in secondary prevention where other options have been exhausted.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
For post-exposure prophylaxis (e.g. needlestick injuries), follow your organisation's protocols for referral and access. Use as recommended by BHIVA/BASHH guidelines.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Preferred
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Preferred
Use an ARB where possible. If an ACEi is required (patient with heart failure or post MI), ramipril is the preferred option.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravitreal injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravitreal injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravitreal injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravitreal injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release tablets
Restrictions / Comments:
Important
Restricted to cardiology
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Specialist to prescribe at least 1 month treatment, prior to transfer of care
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Not assessed for formulary status. An application to APC is required.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Specialist team initiation and at least 3 months of treatment prior to any request for primary care prescribing.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Service not currently provided by any Surrey Heartlands Trusts
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Powder
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Capsules
- Injection
- Oral solution
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Restricted Use - requires microbiology or respiratory approval
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Important
Restricted use of injection with bone pate by ENT to reduce infection of autologous bone pate in mastoid obliteration surgery.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Liaise with Chest Physician. Patients with multi-drug resistant TB should be treated by a specialist centre.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Liaise with Chest Physician. Patients with multi-drug resistant TB should be treated by a specialist centre.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Liaise with Chest Physician. Patients with multi-drug resistant TB should be treated by a specialist centre.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Liaise with Chest Physician. Patients with multi-drug resistant TB should be treated by a specialist centre.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
STAND-BY or PREVENTATIVE treatment is not currently recommended in the NHS Surrey Management of Infection Guidelines. it is difficult for travellers to distinguish between invasive and non-invasive diarrhoea, the overall usefulness of rifaximin as empiric self-treatment remains to be determined. Stand-by treatment of this nature should not be prescribed on the NHS but a private prescription may be issued if appropriate
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Restricted use on recommendation of Gastroenterology consultants for treatment of hepatic encephalopathy.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral lyophilisates
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral lyophilisates
Restrictions / Comments:
Important
For episodic migraine only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHSE commissioned services only. No Surrey Heartlands Trusts are commissioned to provide this.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
For UC & CD. Adults only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
Weekly tablets are 35mg. Daily tablets are 5mg.
NOTE - 30mg tablets are licensed for Paget's disease only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
30mg tablets are licensed for Paget's disease.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Primary Care prescribing on advice from palliative care specialist team
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Restricted Antimicrobial - requires GUM Specialist approval
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
Severe disease only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Specialist initiation and at least one month supply before transfer to primary care
Formulary Status :
Links :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Specialist initiation and at least one month supply before transfer to primary care
Formulary Status :
Links :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
Prescribe generically
Links :
Indication :
Status :
Formulations :
- Oro-dispersible
Restrictions / Comments:
Important
Prescribe generically
Prescribe as generic orodispersible tablets (NOT oral lyophilisates).
For use in patients with swallowing difficulties, nausea or vomitting.
Links :
Indication :
Status :
Formulations :
- Oral lyophilisates
Restrictions / Comments:
Important
Prescribe generically
Prescribe as orodispersible tablets
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Restricted to initiation by respiratory specialists in line with NICE TA461.
https://www.gov.uk/drug-safety-update/roflumilast-daxas-risk-of-suicidal-behaviour
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Haematology use only - treating chronic immune thrombocytopenia as per NICE TA221.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Immediate release tablets
Restrictions / Comments:
Important
Preferred
Patients with severe symptoms, who are obese, co-morbid depression, increased risk of falls or cognitive impairment
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release tablets
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Patches
Restrictions / Comments:
Important
Consider patches if levodopa and / or oral dopamine are not effective in treating nocturnal akinesia
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Patches
Restrictions / Comments:
Important
Preferred
Patients with severe symptoms, who are obese, co-morbid depression, increased risk of falls or cognitive impairment. Consider use of patch if significant daytime symptoms as it has a long duration of action.
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Renal specialist teams only.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
SASH - restricted to paediatrics only.
RSCH - only initiate on recommendation from a tertiary referral centre.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
Restrictions / Comments:
Important
RSCH - only initiate on recommendation from a tertiary referral centre.
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :